Clal Biotechnology Industries Ltd. (TLV:CBI)

TLV:CBI Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.95	5.73	7.44	53.05	68.16
Short-Term Investments	-	-	-	-	13.53
Trading Asset Securities	1.06	7.63	5.44	-	104.81
Cash & Short-Term Investments	5.01	13.36	12.89	53.05	186.5
Cash Growth	-62.48%	3.65%	-75.71%	-71.56%	62.83%
Accounts Receivable	-	-	-	5.53	8.89
Other Receivables	-	0.02	0.65	1.9	1.06
Receivables	-	0.02	0.65	7.44	9.95
Inventory	-	-	-	3.73	4.44
Prepaid Expenses	0.28	0.82	2.59	2.68	2.58
Other Current Assets	0.51	0.49	0.52	10.71	7.63
Total Current Assets	5.8	14.69	16.64	77.61	211.09
Property, Plant & Equipment	1.53	4.73	5.09	18.06	14.94
Long-Term Investments	60.14	138.22	155.69	127.83	138.71
Other Intangible Assets	-	-	-	215.78	241.05
Other Long-Term Assets	0.22	0.75	5.28	5.63	8.23
Total Assets	67.69	158.39	182.69	444.92	614.03
Accounts Payable	-	-	-	14.6	9.62
Accrued Expenses	0.58	1.16	1.01	8.29	7.85
Current Portion of Long-Term Debt	19.17	4.97	-	6.24	5.11
Current Portion of Leases	0.15	0.47	1.85	2.43	2.02
Current Unearned Revenue	-	-	-	2.37	2.33
Other Current Liabilities	0.1	0.07	0.05	1.72	1.36
Total Current Liabilities	20	6.66	2.91	35.65	28.28
Long-Term Debt	-	25.97	27.39	35.86	37.98
Long-Term Leases	1.53	4.35	7.49	9.25	5.72
Long-Term Unearned Revenue	-	-	-	24.52	23.36
Other Long-Term Liabilities	-	-	-	1.26	4.91
Total Liabilities	21.52	36.98	37.79	106.55	100.24
Common Stock	1.61	1.61	1.61	1.61	1.61
Additional Paid-In Capital	1,297	1,296	1,296	1,295	1,295
Retained Earnings	-1,394	-1,332	-1,301	-1,239	-1,113
Treasury Stock	-10	-10	-10	-10	-0.26
Comprehensive Income & Other	142.64	143.76	139.37	125.29	123.72
Total Common Equity	36.63	99.36	126.03	172.59	306.35
Minority Interest	9.53	22.05	18.87	165.78	207.45
Shareholders' Equity	46.17	121.41	144.9	338.37	513.79
Total Liabilities & Equity	67.69	158.39	182.69	444.92	614.03
Total Debt	20.84	35.76	36.73	53.78	50.82
Net Cash (Debt)	-15.83	-22.4	-23.85	-0.73	135.68
Net Cash Growth	-	-	-	-	161.59%
Net Cash Per Share	-0.10	-0.14	-0.15	-0.00	0.84
Filing Date Shares Outstanding	156.85	156.85	156.85	156.85	161.1
Total Common Shares Outstanding	156.85	156.85	156.85	156.85	161.1
Working Capital	-14.2	8.03	13.73	41.96	182.82
Book Value Per Share	0.23	0.63	0.80	1.10	1.90
Tangible Book Value	36.63	99.36	126.03	-43.19	65.3
Tangible Book Value Per Share	0.23	0.63	0.80	-0.28	0.41

Updated Aug 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.